🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Texas › Amarillo

Etid klinik pou Ensifizyans kadyak nan Amarillo, TX

8 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Amarillo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Ap rekriteFaz 3
  • Pharmatex Research, Amarillo
  • Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06424288

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3
  • Pharmatex Research, Amarillo
  • Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06935370

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • PharmaTex Research, LLC, Amarillo
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Ap rekriteFaz 3
  • Research Site, Amarillo
  • Research Site, Amarillo
Laj 18 a 130 · Tout sèks · Mizajou Sep 11, 2026 · NCT06307652

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Ap rekriteFaz 3
  • CON-10045 Amarillo, TX Investigational Site, Amarillo
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • Amarillo, TX Investigative Site 10045, Amarillo
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • PharmaTex Research, LLC, Amarillo
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Amarillo

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.